⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8986509 | 0.98 | — | — | |
| SCHEMBL27590677 | 0.83 | — | — | |
| SCHEMBL5916333 | 0.80 | — | — | |
| SCHEMBL5916338 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL29217832 | 0.77 | — | — | |
| SCHEMBL22389545 | 0.76 | — | — | |
| SCHEMBL3416782 | 0.76 | — | — | |
| SCHEMBL9681361 | 0.75 | — | — | |
| SCHEMBL22389533 | 0.75 | — | — | |
| SCHEMBL9681384 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 346 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11491711-B2 | Method of making 3D printed objects using two distinct light sources | PHOTOCENTRIC LIMITED (GB) | 2022-11-08 | — | — | US | claimed |
| US-20200282638-A1 | METHOD OF MAKING 3D PRINTED OBJECTS USING TWO DISTINCT LIGHT SOURCES | PHOTOCENTRIC LIMITED (GB) | 2020-09-10 | — | — | US | claimed |
| US-10610472-B2 | High energy visible light filter systems with yellowness index values | HIGH PERFORMANCE OPTICS, INC. (US) | 2020-04-07 | — | — | US | claimed |
| US-20180064616-A1 | High Energy Visible Light Filter Systems with Yellowness Index Values | HIGH PERFORMANCE OPTICS, INC. (US) | 2018-03-08 | — | — | US | claimed |
| US-9814658-B2 | High energy visible light filter systems with yellowness index values | HIGH PERFORMANCE OPTICS, INC. (US) | 2017-11-14 | — | — | US | claimed |
| US-20150064123-A1 | HIGH ENERGY VISIBLE LIGHT FILTER SYSTEMS WITH YELLOWNESS INDEX VALUES | HIGH PERFORMANCE OPTICS, INC. | 2015-03-05 | — | — | US | claimed |
| US-8882267-B2 | High energy visible light filter systems with yellowness index values | HIGH PERFORMANCE OPTICS, INC. (US) | 2014-11-11 | — | — | US | claimed |
| WO-2014055513-A1 | SELECTIVE BLUE LIGHT FILTERED OPTIC | HIGH PERFORMANCE OPTICS, INC. (US) | 2014-04-10 | — | — | WO | claimed |
| EP-2591396-A1 | HIGH ENERGY VISIBLE LIGHT FILTER SYSTEMS WITH YELLOWNESS INDEX VALUES | High Performance Optics, Inc. (US) | 2013-05-15 | — | — | EP | claimed |
| US-20120008217-A1 | High Energy Visible Light Filter Systems with Yellowness Index Values | HIGH PERFORMANCE OPTICS, INC. (US) | 2012-01-12 | — | — | US | claimed |
| WO-2012006265-A1 | HIGH ENERGY VISIBLE LIGHT FILTER SYSTEMS WITH YELLOWNESS INDEX VALUES | HIGH PERFORMANCE OPTICS, INC. (US) | 2012-01-12 | — | — | WO | claimed |
| US-12637489-B2 | Silicon containing modified nucleotide analogs | Singular Genomics Systems, Inc. (US) | 2026-05-26 | — | — | US | disclosed |
| US-12630808-B2 | Modified archaeal family b polymerases | Singular Genomics Systems, Inc. (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260125660-A1 | MODIFIED ARCHAEAL FAMILY B POLYMERASES | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260110028-A1 | NUCLEOTIDE ANALOGS AND USES THEREOF | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20050266424-A1 | Real-time sequence determination | HARDIN SUSAN | 2005-12-01 | — | — | US | disclosed |
| US-20050260614-A1 | Methods for real-time single molecule sequence determination | HARDIN SUSAN | 2005-11-24 | — | — | US | disclosed |
| EP-1368460-A2 | REAL-TIME SEQUENCE DETERMINATION | Visigen Biotechnologies, Inc. (US) | 2003-12-10 | — | — | EP | disclosed |
| US-20030064366-A1 | Real-time sequence determination | Life Technologies Corporation | 2003-04-03 | — | — | US | disclosed |
| WO-2002004680-A2 | REAL-TIME SEQUENCE DETERMINATION | VISIGEN BIOTECHNOLOGIES, INC. (US) | 2002-01-17 | — | — | WO | disclosed |